Frank Bennett of Ionis Pharmaceuticals and Adrian Krainer of Cold Spring Harbor Laboratory partnered to treat an incurable disease called spinal muscular atrophy. Their work yielded the disease's first effective drug, Spinraza. They share a $3 million Breakthrough Prize for their work.
沒有留言:
張貼留言